Exploiting tumor-derived IL-10 activity in lymphoma therapy. Tooze R, Klein U. Blood 2025;145:2676-2678.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tooze R, Klein U. Exploiting tumor-derived IL-10 activity in lymphoma therapy. Blood 2025;145:2676-2678.
PMID: 40471622